Literature DB >> 21185609

Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy.

Hassen S Wollebo1, Mahmut Safak, Luis Del Valle, Kamel Khalili, Martyn K White.   

Abstract

JCV causes the CNS demyelinating disease progressive multifocal leukoencephalopathy (PML). After primary infection, JCV persists in a latent state, where viral protein expression and replication are not detectable. NF-κB and C/EBPβ regulate the JCV promoter via a control element, κB, suggesting proinflammatory cytokines may reactivate JCV to cause PML, e.g., in HIV-1/AIDS. Since HIV-1 induces cytokines in brain, including TNF-α, we examined a role for TNF-α in JCV regulation. TNF-α stimulated both early and late JCV transcription. Further, the κB element conferred TNF-α response to a heterologous promoter. Immunohistochemistry of HIV+/PML revealed robust labeling for TNF-α and TNFR-1. These data suggest TNF-α stimulation of κB may contribute to JCV reactivation in HIV+/PML.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185609      PMCID: PMC3074035          DOI: 10.1016/j.jneuroim.2010.11.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  50 in total

1.  Detection of JC virus in the brains of aged patients without progressive multifocal leukoencephalopathy by the polymerase chain reaction and Southern hybridization analysis.

Authors:  M Mori; N Aoki; H Shimada; M Tajima; K Kato
Journal:  Neurosci Lett       Date:  1992-07-20       Impact factor: 3.046

Review 2.  Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.

Authors:  W Fiers
Journal:  FEBS Lett       Date:  1991-07-22       Impact factor: 4.124

Review 3.  The polyomavirus, JCV and its involvement in human disease.

Authors:  Kamel Khalili; Jennifer Gordon; Martyn K White
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region.

Authors:  Martyn K White; Anna Skowronska; Jennifer Gordon; Luis Del Valle; Satish L Deshmane; Antonio Giordano; Kamel Khalili
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

5.  Microarray analysis of glial cells resistant to JCV infection suggests a correlation between viral infection and inflammatory cytokine gene expression.

Authors:  Kate Manley; Gretchen V Gee; Carl P Simkevich; John M Sedivy; Walter J Atwood
Journal:  Virology       Date:  2007-06-06       Impact factor: 3.616

6.  JC virus detection by in situ hybridization in brain tissue from elderly patients.

Authors:  M Mori; H Kurata; M Tajima; H Shimada
Journal:  Ann Neurol       Date:  1991-04       Impact factor: 10.422

Review 7.  HIV-1 infection and AIDS: consequences for the central nervous system.

Authors:  M Kaul; J Zheng; S Okamoto; H E Gendelman; S A Lipton
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

8.  NFAT4 is required for JC virus infection of glial cells.

Authors:  Kate Manley; Bethany A O'hara; Gretchen V Gee; Carl P Simkevich; John M Sedivy; Walter J Atwood
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

9.  Evidence of human polyomavirus BK and JC infection in normal brain tissue.

Authors:  C Elsner; K Dörries
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

10.  JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy.

Authors:  F A White; M Ishaq; G L Stoner; R J Frisque
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more
  28 in total

1.  Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab.

Authors:  Simone Giannecchini; Valeria Clausi; Alessandra Vultaggio; Lisa Macera; Fabrizio Maggi; Francesco Martelli; Alberta Azzi; Enrico Maggi; Andrea Matucci
Journal:  J Neurovirol       Date:  2012-01-27       Impact factor: 2.643

2.  Degradation of polyomavirus JC T-antigen by stress involves the LIP isoform of C/EBP.

Authors:  Anna Bellizzi; Martyn K White; Hassen S Wollebo
Journal:  Cell Cycle       Date:  2015-05-27       Impact factor: 4.534

Review 3.  Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps.

Authors:  Fariha Zaheer; Joseph R Berger
Journal:  Ther Adv Drug Saf       Date:  2012-10

4.  Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.

Authors:  Hassen S Wollebo; Sonia Melis; Kamel Khalili; Mahmut Safak; Martyn K White
Journal:  Virology       Date:  2012-06-30       Impact factor: 3.616

Review 5.  Persistence and pathogenesis of the neurotropic polyomavirus JC.

Authors:  Hassen S Wollebo; Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  Ann Neurol       Date:  2015-03-06       Impact factor: 10.422

6.  Reactivation of human polyomaviruses in immunocompromised states.

Authors:  Kari Wiedinger; Constantine Bitsaktsis; Sulie Chang
Journal:  J Neurovirol       Date:  2014-01-31       Impact factor: 2.643

7.  Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65.

Authors:  Hassen S Wollebo; Anna Bellizzi; Dominique H Cossari; Mahmut Safak; Kamel Khalili; Martyn K White
Journal:  J Neurovirol       Date:  2015-03-20       Impact factor: 2.643

Review 8.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

9.  Immune suppression of JC virus gene expression is mediated by SRSF1.

Authors:  Rahsan Sariyer; Francesca Isabella De-Simone; Jennifer Gordon; Ilker Kudret Sariyer
Journal:  J Neurovirol       Date:  2016-03-07       Impact factor: 2.643

10.  Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy.

Authors:  Hassen S Wollebo; Bianca Cotto; Radhika Adiga; Dianne Langford; Martyn K White
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.